In the first week of December, in the UMC Utrecht extra attention was paid to antibiotic resistance and responsible antibiotic use during a special awareness campaign. By using too many and incorrect antibiotics, more and more bacteria are becoming insensitive to antibiotics. It is possible that infections such as pneumonia or cystitis may not be treated as well. This is serious because it can have very serious consequences for the patient.
In the context of the campaign, special communication materials were developed, such as articles on CONNECT (intranet), UMC Utrecht website and a poster. More info can be found on www.mijnumc.nl/antibiotica (in Dutch).
Flu antiviral has bigger benefits for sicker, older patients
A Europe-wide study conducted over three flu seasons finds that the antiviral drug, oseltamivir, can help people recover from flu-like illness about one-day sooner on average, with older sicker patients who have been unwell for longer recovering two-to-three days sooner. Published in The Lancet this week, the European Commission-funded ‘ALIC4E’ study was led by the University of Oxford (UK) and UMC Utrecht (The Netherlands).
Despite being stockpiled since 2006 and being widely prescribed during the swine flu outbreak in 2009, oseltamivir remains one of the most controversial drugs in use. This is due to a lack of evidence from independent clinical trials to demonstrate its effectiveness in everyday care, and whether it benefits key groups of patients. A member of a class of drugs called neuraminidase inhibitors, oseltamivir is recommended by public health agencies worldwide for treating and preventing severe outbreaks of seasonal and pandemic influenza.
“Doodziek van een snotneus”
Louis Bont (Algemeen Dagblad)
“Ik lag in het ziekenhuis en dacht, dit kan ik ook”
Marc Bonten (Observant)
“Voor het eerst beseffen we: genezen van hiv is mogelijk”